Breaking News Instant updates and real-time market news.

GDDY

GoDaddy

$70.52 /

+0.525 (+0.75%)

09:17
01/29/20
01/29
09:17
01/29/20
09:17

GoDaddy acquires Over

GoDaddy has entered into a definitive agreement to acquire Over, the company behind the Over app that helps entrepreneurs and small businesses grow their brands by creating visual content for any platform online. Financial details of the transaction were not disclosed. The Over app has more than one million monthly active users and is used by people in over 150 countries. The Over app will continue to be offered as a standalone app on the Apple App Store and Google Play Store. GoDaddy will maintain Over's office in Cape Town, South Africa.

  • 13

    Feb

GDDY GoDaddy
$70.52 /

+0.525 (+0.75%)

01/28/20 Jefferies
Jefferies favors Facebook, Alphabet in large-cap internet ahead of earnings
01/16/20 SunTrust
GoDaddy price target lowered to $89 from $93 at SunTrust
12/10/19 Jefferies
Jefferies small business survey points to 'more love' for internet leaders
12/05/19 William Blair
GoDaddy shares remain undervalued, says William Blair

TODAY'S FREE FLY STORIES

Hot Stocks
PhaseBio expects readout of PB1046 clincal trial in 2021 » 08:05
03/30/20
03/30
08:05
03/30/20
08:05
PHAS

PhaseBio

$3.32 /

+0.17 (+5.40%)

PB1046, a first-in-class,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Alphabet, Snap, Facebook price targets lowered at JMP Securities » 08:05
03/30/20
03/30
08:05
03/30/20
08:05
FB

Facebook

$156.85 /

-6.48 (-3.97%)

, SNAP

Snap

$12.17 /

+0.21 (+1.76%)

, GOOGL

Alphabet Class A

$1,109.46 /

-53.25 (-4.58%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
PhaseBio reports Q4 EPS (39c), consensus (40c) » 08:05
03/30/20
03/30
08:05
03/30/20
08:05
PHAS

PhaseBio

$3.32 /

+0.17 (+5.40%)

Reports Q4 revenue $0.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Genmab should see little impact from COVID-19, says H.C. Wainwright » 08:05
03/30/20
03/30
08:05
03/30/20
08:05
GMAB

Genmab

$20.17 /

-0.09 (-0.44%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Coupa Software names Michael van Keulen as chief procurement officer » 08:05
03/30/20
03/30
08:05
03/30/20
08:05
COUP

Coupa Software

$146.47 /

+4.52 (+3.18%)

, LULU

Lululemon

$188.84 /

-11.96 (-5.96%)

Coupa Software (COUP)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
LightInTheBox adding free packs of medical face masks to parcels shipped » 08:03
03/30/20
03/30
08:03
03/30/20
08:03
LITB

LightInTheBox

$0.80 /

+0.0273 (+3.53%)

LightInTheBox announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Zillow price target raised to $30 from $25 at Wedbush » 08:03
03/30/20
03/30
08:03
03/30/20
08:03
ZG

Zillow

$35.99 /

-2.5 (-6.50%)

Wedbush analyst Ygal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Dare Bioscience reports FY19 EPS (97c), consensus (94c) » 08:02
03/30/20
03/30
08:02
03/30/20
08:02
DARE

Dare Bioscience

$0.90 /

-0.0499 (-5.25%)

"During the fourth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Lear adds capacity to make protective face masks » 08:01
03/30/20
03/30
08:01
03/30/20
08:01
LEA

Lear

$89.07 /

-6.645 (-6.94%)

Lear has added capacity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
AT&T put buyer realizes 13% same-day gains » 08:00
03/30/20
03/30
08:00
03/30/20
08:00
T

AT&T

$29.86 /

-0.68 (-2.23%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Orgenesis CEO says "well-positioned" to drive long-term shareholder value » 08:00
03/30/20
03/30
08:00
03/30/20
08:00
ORGS

Orgenesis

$3.23 /

-0.095 (-2.86%)

Orgenesis provides the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Cerner upgraded to Outperform from Market Perform at Cowen » 08:00
03/30/20
03/30
08:00
03/30/20
08:00
CERN

Cerner

$59.93 /

-1.09 (-1.79%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Morgan Stanley ups Cognizant to Equal Weight as slower transformation priced in » 07:59
03/30/20
03/30
07:59
03/30/20
07:59
CTSH

Cognizant

$46.59 /

-3.23 (-6.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Wendy's price target lowered to $15 from $24 at Piper Sandler » 07:59
03/30/20
03/30
07:59
03/30/20
07:59
WEN

Wendy's

/

+

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Masonite price target lowered to $82 from $95 at Wedbush » 07:59
03/30/20
03/30
07:59
03/30/20
07:59
DOOR

Masonite

$45.06 /

-8.03 (-15.13%)

Wedbush analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rhythm Pharmaceuticals completes rolling submission of NDA for setmelanotide » 07:58
03/30/20
03/30
07:58
03/30/20
07:58
RYTM

Rhythm Pharmaceuticals

$14.06 /

-0.58 (-3.96%)

Rhythm Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Darden price target raised to $63 from $50 at Piper Sandler » 07:58
03/30/20
03/30
07:58
03/30/20
07:58
DRI

Darden

$54.67 /

-5.94 (-9.80%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Oyster Point Pharma experiences impact to trial sites amid COVID-19 » 07:57
03/30/20
03/30
07:57
03/30/20
07:57
OYST

Oyster Point Pharma

$35.14 /

-0.21 (-0.59%)

Due to the COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Carvana price target lowered to $67 from $100 at Baird » 07:57
03/30/20
03/30
07:57
03/30/20
07:57
CVNA

Carvana

/

+

Baird analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Masonite removed from Best Ideas List at Wedbush » 07:57
03/30/20
03/30
07:57
03/30/20
07:57
DOOR

Masonite

$45.06 /

-8.03 (-15.13%)

Wedbusha removed Masonite…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Tempur Sealy a favored 'bounce-back' idea for 2021 at Piper Sandler » 07:57
03/30/20
03/30
07:57
03/30/20
07:57
TPX

Tempur Sealy

$45.92 /

-2.09 (-4.35%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Oyster Point Pharma completes enrollment in ONSET-2 Phase 3 trial of OC-01 » 07:57
03/30/20
03/30
07:57
03/30/20
07:57
OYST

Oyster Point Pharma

$35.14 /

-0.21 (-0.59%)

Oyster Point Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pluristem treats first three COVID-19 patients in Israel under compassionate use » 07:56
03/30/20
03/30
07:56
03/30/20
07:56
PSTI

Pluristem

$3.06 /

-0.175 (-5.42%)

Pluristem Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Immunovant announces clinical results from ongoing Phase 2a study of IMVT-1401 » 07:55
03/30/20
03/30
07:55
03/30/20
07:55
IMVT

Immunovant

$13.54 /

+0.92 (+7.29%)

Immunovant announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Moderna to host conference call » 07:55
03/30/20
03/30
07:55
03/30/20
07:55
MRNA

Moderna

$30.01 /

+2.1 (+7.52%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.